AlphaCentric Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Buy
887
+66
+8% +$18.3K 0.17% 162
2026
Q1
$242K Buy
821
+47
+6% +$14K 0.24% 131
2025
Q4
$211K Buy
+774
New +$210K 0.21% 138
2024
Q4
$194K Sell
837
-20
-2% -$4.6K 0.19% 120
2024
Q3
$189K Sell
857
-61
-7% -$12.6K 0.14% 139
2024
Q2
$180K Buy
918
+13
+1% +$2.69K 0.13% 130
2024
Q1
$195K Sell
905
-62
-6% -$13K 0.12% 133
2023
Q4
$204K Buy
+967
New +$206K 0.14% 111

Other funds holding CME

AlphaCentric Advisors's CME Position: Q2 2026 in Review

AlphaCentric Advisors increased its CME Group (CME) stake by 8% in Q2 2026, buying an estimated $18.3K and bringing the position to 887 shares worth $196K. The position accounts for 0.17% of the portfolio, ranked #162.

AlphaCentric Advisors first reported a position in CME in Q4 2023 and has held it in 8 quarters since. The position peaked at $242K in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • AlphaCentric Advisors held 887 shares of CME Group worth $196K as of Q2 2026.
  • AlphaCentric Advisors bought 66 CME Group shares in Q2 2026, an estimated $18.3K.
  • CME Group made up 0.17% of AlphaCentric Advisors's portfolio in Q2 2026, its #162 holding.
  • AlphaCentric Advisors first reported a position in CME Group in Q4 2023 and has held it in 8 quarters since.
  • AlphaCentric Advisors's CME Group position peaked at $242K in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.